2013
DOI: 10.1073/pnas.1300677110
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models

Abstract: It is well-established that subcompartments of endoplasmic reticulum (ER) are in physical contact with the mitochondria. These lipid raft-like regions of ER are referred to as mitochondria-associated ER membranes (MAMs), and they play an important role in, for example, lipid synthesis, calcium homeostasis, and apoptotic signaling. Perturbation of MAM function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial pres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

25
367
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 404 publications
(409 citation statements)
references
References 50 publications
25
367
3
Order By: Relevance
“…Second, upregulation of SMase and the resulting increase in ceramide are known to alter the size and composition of lipid raft domains (Dinkla et al , 2012), such as MAM. Therefore, an increased localization of C99 in MAM in AD may explain the upregulation of ER–mitochondria connections and MAM functionality seen in the disease (Area‐Gomez et al , 2012; Hedskog et al , 2013). Finally, given the detrimental effect of ceramide on mitochondrial supercomplex assembly and respiratory chain activity (Zigdon et al , 2013), we conclude that its accumulation is likely to be a primary cause of mitochondrial dysfunction in AD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Second, upregulation of SMase and the resulting increase in ceramide are known to alter the size and composition of lipid raft domains (Dinkla et al , 2012), such as MAM. Therefore, an increased localization of C99 in MAM in AD may explain the upregulation of ER–mitochondria connections and MAM functionality seen in the disease (Area‐Gomez et al , 2012; Hedskog et al , 2013). Finally, given the detrimental effect of ceramide on mitochondrial supercomplex assembly and respiratory chain activity (Zigdon et al , 2013), we conclude that its accumulation is likely to be a primary cause of mitochondrial dysfunction in AD.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, MAM functionality (Area‐Gomez et al , 2012) and ER–mitochondrial apposition (Area‐Gomez et al , 2012; Hedskog et al , 2013) are increased in AD.…”
Section: Introductionmentioning
confidence: 99%
“…[61][62][63] and paving the way to studies showing upregulated expression of MAM-associated proteins in human and mouse AD brains prior to the appearance of amyloid plaques. 64 Thus, altered lipid-MERC function might trigger amyloid plaques formation, which is at the core of the 'amyloid hypothesis'; in this scenario, the MAM and the amyloid hypothesis are not mutually exclusive, but place the loss of lipid homeostasis upstream of amyloid plaques deposition. Given the compelling evidence supporting the MAM hypothesis and the lack of therapies for AD patients, studies addressing this pathology as a brain metabolic disorder in lipid homeostasis are warranted.…”
Section: The Lipid-merc: a Site Of Phospholipid Biosynthesis And Trafmentioning
confidence: 99%
“…Conversely, PACS-2 knockdown protects liver from overnutritioninduced steatosis and optimizes mitochondrial respiration and insulin sensitivity (Arruda et al, 2014). Aberrantly elevated PACS-2 and MAM formation are also found in neurons from Alzheimer's patients and Alzheimer's mouse models, suggesting that the deleterious consequences from abnormally strong MAM formation in this disease may also result from dysregulated PACS-2 expression (Area-Gomez et al, 2012; Hedskog et al, 2013).…”
Section: Introductionmentioning
confidence: 99%